1. -- U.S. stock futures on Monday pointed lower and European stocks declined after Federal Reserve officials, including Chair Janet Yellen, made a case for an increase in interest rates, perhaps as early as September.
Stocks on Friday closed mixed following Yellen's comments at the Economic Policy Symposium in Jackson Hole, Wyo.
2. -- Billionaire activist Carl Icahn late Friday reported that he had acquired 2.3 million additional shares of Herbalife (HLF).
3. -- Roche (RHHBY) , the Swiss drugmaker, said Monday the Food and Drug Administration issued an Emergency Use Authorization for its Zika rRT-PCR Test, a test for the Zika virus that has been associated with microcephaly, a birth defect.
4. -- Carlyle (CG) is weighing whether to withdraw from its hedge fund activities, as the private-equity group struggles with its offerings and as one of its remaining vehicles has shrunk by almost 90% in two years.
Another Carlyle hedge fund, Vermillion, was reconfigured last year. In February, Carlyle shut its fund of funds business, Diversified Global Asset Management.
25 Canada Square, Level 33, office 50, Canary Wharf London, E14 5LQ +44 20 3608 6256
World Financial Markets - 0700 17 600 Varchev Exchange - 0700 115 44
Varchev Finance Ltd is registered in the FCA (FINANCIAL CONDUCT AUTHORITY) with a passport in the United Kingdom: FCA, United Kingdom - registration number: 494 045, which allows provision of financial services in the United Kingdom.
Varchev Finance Ltd strictly comply with the statutes of the European directive MiFID (Markets in Financial Instruments). targeting increased efficiency, transparency and uniformity of financial instruments.
Varchev Finance Ltd is authorized and regulated by the Financial Supervision Commission - Sofia, Bulgaria: License number RG-03-02-05 / 15.03.2006
The information on this site is not intended for distribution or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63,41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.